DPP-4 inhibitor
DPP-4 inhibitor is a pharmaceutical drug with 18 clinical trials. Currently 3 active trials ongoing. Historical success rate of 92.9%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.7%
13 of 15 finished
13.3%
2 ended early
3
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparative Effectiveness of Empagliflozin in the US
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Clinical Trials (18)
Comparative Effectiveness of Empagliflozin in the US
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
Replication of the CANVAS Diabetes Trial in Healthcare Claims
Replication of the EMPAREG Diabetes Trial in Healthcare Claims
Replication of the DECLARE Diabetes Trial in Healthcare Claims
Replication of the LEADER Diabetes Trial in Healthcare Claims
GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide
Study of Sulphonylurea Synergy With DPP4 Inhibitors
Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors
Approaches To Therapy Escalation In T2D
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
Fatty Liver Study in Patients With Type II Diabetes
Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18